Motion · S2M-00667 · 26 Nov 2003

Photodynamic Therapy for the Treatment of Wet Age-Related Macular Degeneration (AMD)

Lodged by Kate Maclean Members' Business Motion 47 supporters

The motion

That the Parliament notes the recent decision by NHS Quality Improvement Scotland on the use of photodynamic therapy for the treatment of wet age-related macular degeneration (AMD) and acknowledges that photodynamic therapy is the only effective treatment for wet AMD, the most aggressive form of the disease and the leading cause of blindness in the UK, with around 650 new patients diagnosed with wet AMD in Scotland every year; is deeply concerned that funding has not been made available for clinicians to treat on the NHS those patients who urgently require the therapy, and endorses the demand by the Royal National Institute of the Blind Scotland and the Macular Disease Society that the Scottish Executive ensures that funding is immediately provided by all NHS boards, thereby saving the sight of those who could benefit from the therapy.

Supporters (47)

Source: the Scottish Parliament motions and amendments record.